 |
Name: Rufus O. AKINYEMI
|
| Designation: Professor |
| Institute: INSTITUTE FOR ADVANCED MEDICAL RESEARCH AND TRAINING |
| Phone Number: +234 8033704384 |
|
Google Scholar Profile
Research Gate Profile
ORCID Profile
|
|
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Alternate Email Address 1: This email address is being protected from spambots. You need JavaScript enabled to view it.
Alternate Email Address 2: This email address is being protected from spambots. You need JavaScript enabled to view it.
|
|
Biography:
Professor Rufus Akinyemi, winner of the 2023 Gold Medal Prize (Life Sciences) of the Nigerian Academy of Science (NAS), is a Professor of Geriatric Neurology and Translational Neuroscience in the Institute for Advanced Medical Research and Training and Deputy Director of the Centre for Genomics and Precision Medicine, College of Medicine, University of Ibadan, Nigeria. He is also a consultant neurologist to the University College Hospital, Ibadan, Nigeria. He holds a PhD from Newcastle University, United Kingdom; an MSc in Cell Biology and Genetics and a Bachelor of Medicine and Surgery from the University of Ibadan, Nigeria. He also holds a fellowship of the National Postgraduate Medical College of Nigeria in Internal Medicine and Neurology.
His research focuses on vascular and degenerative brain disorders using a translational bench-bedside-community framework. Prof Akinyemi has led multiple funded projects including the African Neurobiobank for Precision Stroke Medicine ELSI Project. He currently serves as the African PI of the NIH/ NIA -funded READD – ADSP Project and recently spearheaded the establishment of the African Stroke Organization (ASO) and the African Dementia Consortium (AfDC). He has served on the steering committees of multiple global bodies including the International Stroke Genetics Consortium and the H3Africa Consortium. He currently leads the CoMUI Biobanking Committee. His work on stroke and dementia has attracted notable recognition including the James Kimani Award of the Society of Neuroscientists of Africa, the Bruce Schoenberg International Award in Neuroepidemiology of the American Academy of Neurology, the Atlantic fellowship of the Global Brain Health Institute and more recently he was elected fellow of The Academy of Medicine Specialties of Nigeria. He has over 220 peer - reviewed publications in reputable international journals including the Lancet, Science, New England Journal of Medicine and Nature. He has an H-index of 55 and 61,246 citations.
|
Current Research and Capacity Building Projects including Grants.
1. Title: Recruitment and Retention for Alzheimer’s Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) Study
Funder: National Institute of Ageing, National Institute of Health, USA.
Brief Summary: The READD ADSP Study is the largest Dementia study in Africa which aims to build a resource that greatly expands the representation of currently underrepresented African ancestry (African American (AA)) and Africans (AF)) and Hispanic/Latnix (HL) individuals in AD genetics studies. This project will help to identify multiple influential genetic mechanisms, expand our understanding of the Alzheimer’s Disease have and to broaden the biological scope for developing potential therapies.
Role: Principal Investigator (African Sites)
2. Title: Origins Of Alzheimer Disease in African Americans Investigators (ORIGINS PROJECT)
Funder: National Institute of Ageing, National Institute of Health, USA.
Brief Summary: The specific aim of this study is to deepen genetic, ancestral, and clinical characterization of our 100+ African American multiplex families, to educate African American individuals and families about brain donation to advance interest, decision-making and opportunities for participation, to extend genomic analyses of Alzheimer’s Disease to cardiovascular phenotypes, to determine the genetic patterns of AD susceptibility in AFa individuals, and to evaluate the molecular and genomic function of known risk and/or protective variants.
Role: African Sites Principal Investigator
3. Title: Ibadan Brain Bank Project. (Dementia, Ageing and Neurodegeneration) [IBADAN Brain Bank]
Funder: College of Ibadan, University of Ibadan.
Brief Summary: The aim of this study is to determine awareness and willingness to donate brain for research purpose, establish a pilot brain bank and evaluate the immunohistochemical features of ageing – associated degenerative Alzheimer pathology in brain tissue from a pilot cohort of adult/ older Nigerians.
Role: Principal Investigator
4. Title: Vascular Health, Frailty and Cognition in Ageing Nigerians Study [VALIANT]
Funder: Global Brain Health Institute
Brief Summary: The overarching goal of this study is to establish a population-based cohort of older adults (50+ years) and investigate the association of cardiovascular health (CVH) with cognition and frailty longitudinally.
Role: Principal Investigator
5. Title: International Cohort Study of Chronic Neuropsychiatric Sequeale of SARS-Cov-2
Funder: National Institute of Health, USA
Brief Summary: The purpose of this study is to describe the longitudinal course, epidemiological risk/resiliency factors, and environmental interactions predictive of cognitive decline and progress to Alzheimer’s disease following SARS-CoV-2 infection in adults over 65 years of age from Ancestral and Admixed populations, to assess gene x environment interactions predictive of risk and resilience to cognitive decline and progression to Alzheimer’s disease in ancestral and admixed populations, To describe the impact of SARS-CoV-2 infection on neuroimaging networks associated with neurological symptoms (anosmia and cognitive impairment) as predictors of progression to Alzheimer’s dementia in ancestral and admixed populations and to describe the impact of SARS-CoV-2 infection on serological biomarkers of Alzheimer’s disease as predictors of cognitive impairment and progression to Alzheimer’s dementia in ancestral and admixed populations.
Role: Multiple Principal Investigator
6. Title: African Neurobiobank Precision Stroke Medicine; ELSI Project Advanced Training on Ethical Legal and Social Implications of Neurobibank and Genetics Counselling
Funder: National Institute of Health, USA
Brief Summary: The overarching goal of the African Neurobiobank for Precision Stroke Medicine—ELSI Project is to identify, examine, and develop novel approaches to address ELSI issues of stroke genomics and biobanking in SSA. The project will develop novel, context-relevant, and culturally appropriate interventions to enhance community understanding and participation in stroke genomic and biobanking activities in an equitable, trusting, and fair space while building sustainable careers in genetic counseling and biobanking science.
Role: Principal Investigator
7. Title: African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES)
Funder: National Institute of Health, USA
Brief Summary: The purpose of the study is to develop and validate an innovative interactive mobile-health-driven community-based SISS in the selected urban (Ibadan) and rural (Igbo-Ora) demographic surveillance sites (DSS) in Nigeria as a scalable effective model that can be useful in other countries for enhancing immediate stroke recognition, early complete notification, and timely presentation (reduced onset-to-door time) in appropriate healthcare facilities. The study also aims to determine the stroke prevalence at these sites over a 36-month period.
Role: Co-Investigator
8. Title: International Cohort Study of Chronic Neuropsychiatric Sequeale of SARS-Cov-2
Funder: National Institute of Health
Brief Summary: The purpose of this study is to describe the longitudinal course, epidemiological risk/resiliency factors, and environmental interactions predictive of cognitive decline and progress to Alzheimer’s disease following SARS-CoV-2 infection in adults over 65 years of age from Ancestral and Admixed populations, to assess gene x environment interactions predictive of risk and resilience to cognitive decline and progression to Alzheimer’s disease in ancestral and admixed populations, To describe the impact of SARS-CoV-2 infection on neuroimaging networks associated with neurological symptoms (anosmia and cognitive impairment) as predictors of progression to Alzheimer’s dementia in ancestral and admixed populations and to describe the impact of SARS-CoV-2 infection on serological biomarkers of Alzheimer’s disease as predictors of cognitive impairment and progression to Alzheimer’s dementia in ancestral and admixed populations.
Role: Multiple Principal Investigator
SELECTED PUBLICATIONS
1. Akinyemi RO, Ovbiagele BO, Adeniji OA, Sarfo FS, Abd- Allah, F, Adoukonou T, Ogah OS, Naidoo P, Damasceno A, Walker RW, Ogunniyi A, Kalaria RN, Owolabi MO. (2021). Stroke in Africa: profile, progress, prospects and priorities. Nature Reviews Neurology;17(10):634-656. doi: 10.1038/s41582-021-00542-4. [Impact Factor: 44.7https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441961/">Stroke in Africa: profile, progress, prospects and priorities - PMC (nih.gov)
2. Akinyemi RO, Yaria J, Ojagbemi A, Guerchet M, Okubadejo N, Njamnshi AK, Sarfo FS, Akpalu A, Ogbole G, Ayantayo T, Adokonou T, Paddick SM, Ndetei D, Bosche J, Ayele B, Damas A, Coker M, Mbakile-Mahlanza L, Ranchod K, Bobrow K, Anazodo U, Damasceno A, Seshadri S, Pericak-Vance M, Lawlor B, Miller BL, Owolabi M, Baiyewu O, Walker R, Gureje O, Kalaria RN, Ogunniyi A; African Dementia Consortium (AfDC) (2022). Dementia in Africa: Current evidence, knowledge gaps, and future directions. Alzheimers and Dementia;18 (4):790-809. doi: 10.1002/alz.12432 [Impact Factor: 16.7https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957626/">Dementia in Africa: Current evidence, knowledge gaps and future directions - PMC (nih.gov)
3. Owolabi MO, Sarfo F, Akinyemi R, Gebregziabher M, Akpa O, Akpalu A, Wahab K, Obiako R, Owolabi L, Ovbiagele B; SIREN Team; as part of H3Africa Consortium. (2018). Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Global Health ;6(4): e436-e446. doi: 10.1016/S2214-109X (18)30002-0. [Impact Factor: 38·9https://pubmed.ncbi.nlm.nih.gov/29496511/">Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study - PubMed (nih.gov)
4. Akinyemi R, Tiwari HK, Arnett DK, Ovbiagele B, Irvin MR, Wahab K, Sarfo F, Srinivasasainagendra V, Adeoye A, Perry RT, Akpalu A, Jenkins C, Arulogun O, Gebregziabher M, Owolabi L, Obiako R, Sanya E, Komolafe M, Fawale M, Adebayo P, Osaigbovo G, Sunmonu T, Olowoyo P, Chukwuonye I, Obiabo Y, Onoja A, Akinyemi J, Ogbole G, Melikam S, Saulson R, Owolabi M; SIREN Investigators.(2018). APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke. Acta Neurologica Scandinavica ;137(1):133-141 doi: 10.1111/ane.12847. [Impact Factor: 3.9https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716854/">APOL1, CDKN2A/CDKN2B and HDAC9 polymorphisms and small vessel ischemic stroke - PMC (nih.gov)
5. Mishra A…………. Akinyemi R……. Fornage M, Liaw YP, Seshadri S, Fernández-Cadenas I, Walters RG, Ruff CT, Owolabi MO, Huffman JE, Milani L, Kamatani Y, Dichgans M, Debette S. (2022). Stroke genetics informs drug discovery and risk prediction across ancestries. Nature; 611(7934):115-123. doi: 10.1038/s41586-022-05165-3. [Impact Factor: 69.5https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524349/">Stroke genetics informs drug discovery and risk prediction across ancestries - PMC (nih.gov)
6. Akinyemi RO, Allan L, Owolabi MO, Akinyemi JO, Ogbole G, Ajani A, Firbank M, Ogunniyi A, Kalaria RN. (2014). Profile and determinants of vascular cognitive impairment in African stroke survivors: the CogFAST Nigeria Study. Journal of Neurological Sciences; 346 (1-2):241-9. doi: 10.1016 /j. jns. 2014.08.042. [Impact Factor: 4.5https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827373/">Stroke injury, cognitive impairment and vascular dementia - PMC (nih.gov)
7. Chen A, Akinyemi RO, Hase Y, Firbank MJ, Ndung'u MN, Foster V, Craggs LJ, Washida K, Okamoto Y, Thomas AJ, Polvikoski TM, Allan LM, Oakley AE, O'Brien JT, Horsburgh K, Ihara M, Kalaria RN. (2016). Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain; 139 (Pt 1):242-58. doi: 10.1093/brain/awv328. [Impact Factor:15.3https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905522/">Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia - PMC (nih.gov)
8. Akinyemi RO, Allan LM, Oakley A, Kalaria RN. (2017). Hippocampal Neurodegenerative Pathology in Post-stroke Dementia Compared to Other Dementias and Aging Controls. Frontiers in Neuroscience.; 11:717. doi: 10.3389/fnins.2017.00717. [Impact Factor: 5.2https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742173/">Hippocampal Neurodegenerative Pathology in Post-stroke Dementia Compared to Other Dementias and Aging Controls - PMC (nih.gov)
9. Akinyemi RO, Akinwande K, Diala S, Adeleye O, Ajose A, Issa K, Owusu D, Boamah I, Yahaya IS, Jimoh AO, Imoh L, Fakunle G, Akpalu A, Sarfo F, Wahab K, Sanya E, Owolabi L, Obiako R, Osaigbovo G, Komolafe M, Fawale M, Adebayo P, Olowoyo P, Obiabo Y, Sunmonu T, Chukwuonye I, Balogun O, Adeoye B, Oladele F, Olowoniyi P, Adeyemi F, Lezzi A, Falayi AT, Fasanya M, Ogunwale K, Adeola O, Olomu O, Aridegbe O, Laryea R, Uvere E, Faniyan M, Melikam E, Tagge R, Akpa O, Akinyemi J, Arulogun O, Tiwari HK, Ovbiagele B, Owolabi MO.(2018). Biobanking in a Challenging African Environment: Unique Experience from the SIREN Project. Biopreservation and Biobanking. Jun;16(3):217-232. doi: 10.1089/ bio. 2017.0113 [Impact Factor: 2.30https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995267/">Biobanking in a Challenging African Environment: Unique Experience from the SIREN Project - PMC (nih.gov)
10. Singh A, Arulogun O, Akinyemi J, Nichols M, Calys-Tagoe B, Ojebuyi B, Jenkins C, Obiako R, Akpalu A, Sarfo F, Wahab K, Sunday A, Owolabi LF, Adigun M, Afolami I, Olorunsogbon O, Ogunronbi M, Melikam ES, Laryea R, Asibey S, Oguike W, Melikam L, Sule A, Titiloye MA, Yahaya IS, Bello A, Kalaria RN, Jegede A, Owolabi M, Ovbiagele B, Akinyemi R. (2022). Biological sample donation and informed consent for neurobiobanking: Evidence from a community survey in Ghana and Nigeria. PLoS One;17(8): e0267705. doi: 10.1371 /journal. pone.0267705. [Impact Factor: 3.7https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371301/">Biological sample donation and informed consent for neurobiobanking: Evidence from a community survey in Ghana and Nigeria - PMC (nih.gov)
11. Besharati S, Akinyemi R. Accelerating African neuroscience to provide an equitable framework using perspectives from West and Southern Africa. Nat Commun. 2023 Dec 7;14(1):8107. Accelerating African neuroscience to provide an equitable framework using perspectives from West and Southern Africa - PMC (nih.gov)
12. Kalaria RN, Akinyemi RO, Paddick SM, Ihara M. Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health. Expert Rev Neurother. 2023 Nov 2:1-20. URL: Full article: Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health (tandfonline.com)
13. Asowata OJ, Okekunle AP, Akpa OM, Fakunle AG, Akinyemi JO, Komolafe MA, Sarfo FS, Akpalu AK, Obiako R, Wahab KW, Osaigbovo Osawaru GO, Owolabi LF, Jenkins CM, Calys-Tagoe BNL, Arulogun OS, Ogbole GI, Ogah OS, Lambert AT, Ibinaiye PO, Adebayo PB, Singh A, Adeniyi SA, Mensah YB, Laryea RY, Balogun O, Chukwuonye II, Akinyemi RO, Ovbiagele B, Owolabi MO. Risk Assessment Score and Chi-Square Automatic Interaction Detection Algorithm for Hypertension Among Africans: Models From the SIREN Study. Hypertension. 2023 Dec;80(12):2581-2590. URL: Risk Assessment Score and Chi-Square Automatic Interaction Detection Algorithm for Hypertension Among Africans: Models From the SIREN Study | Hypertension (ahajournals.org)
14. Adewale BA, Coker MM, Ogunniyi A, Kalaria RN, Akinyemi RO. Biomarkers and Risk Assessment of Alzheimer's Disease in Low- and Middle-Income Countries. J Alzheimers Dis. 2023;95(4):1339-1349. URL: Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries - IOS Press
15. Adeniji O, Adeleye O, Akinyemi J, Otubogun F, Ogunde G, Ogunrombi M, Adesina D, Wahab A, Ogunlana M, Alimi T, Akinyemi R. Organized multi-disciplinary stroke team care improves acute stroke outcomes in resource limited settings; Results of a retrospective study from a Nigerian tertiary hospital. J Stroke Cerebrovasc Dis. 2023 Oct;32(10):107307. URL: Organized multi-disciplinary stroke team care improves acute stroke outcomes in resource limited settings; Results of a retrospective study from a Nigerian tertiary hospital - Journal of Stroke and Cerebrovascular Diseases (strokejournal.org)
16. Doumatey AP, Bentley AR, Akinyemi R, Olanrewaju TO, Adeyemo A, Rotimi C. Genes, environment, and African ancestry in cardiometabolic disorders. Trends Endocrinol Metab. 2023 Oct;34(10):601-621. URL: Genes, environment, and African ancestry in cardiometabolic disorders - PubMed (nih.gov)
17. Sarfo FS, Obiako R, Nichols M, Akinyemi JO, Fakunle A, Akpa O, Arulogun O, Akinyemi R, Jenkins C, Ovbiagele B, Owolabi M. Knowledge and perspectives of community members on risk assessment for stroke prevention using mobile health approaches in Nigeria. J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107265. URL: Knowledge and perspectives of community members on risk assessment for stroke prevention using mobile health approaches in Nigeria - PubMed (nih.gov)
18. Adebayo O, Akpa O, Asowata OJ, Fakunle A, Sarfo FS, Akpalu A, Wahab K, Obiako R, Komolafe M, Owolabi L, Osaigbovo GO, Okekunle AP, Sunmonu T, Tiwari HK, Jenkins C, Arulogun O, Appiah L, Akinyemi J, Adeoye AM, Ogbole G, Yaria J, Arnett D, Adebayo P, Calys-Tagoe B, Ogah OS, Balogun O, Ogunjimi L, Mensah Y, Agbogu-Ike OU, Akinyemi R, Ovbiagele B, Owolabi MO; SIREN. Determinants of First-Ever Stroke Severity in West Africans: Evidence From the SIREN Study. J Am Heart Assoc. 2023 Jun 20;12(12):e027888. URL: Determinants of First‐Ever Stroke Severity in West Africans: Evidence From the SIREN Study - PMC (nih.gov)
19. Duering M, Biessels GJ, Brodtmann A, Chen C, Cordonnier C, de Leeuw FE, Debette S, Frayne R, Jouvent E, Rost NS, Ter Telgte A, Al-Shahi Salman R, Backes WH, Bae HJ, Brown R, Chabriat H, De Luca A, deCarli C, Dewenter A, Doubal FN, Ewers M, Field TS, Ganesh A, Greenberg S, Helmer KG, Hilal S, Jochems ACC, Jokinen H, Kuijf H, Lam BYK, Lebenberg J, MacIntosh BJ, Maillard P, Mok VCT, Pantoni L, Rudilosso S, Satizabal CL, Schirmer MD, Schmidt R, Smith C, Staals J, Thrippleton MJ, van Veluw SJ, Vemuri P, Wang Y, Werring D, Zedde M, Akinyemi RO, Del Brutto OH, Markus HS, Zhu YC, Smith EE, Dichgans M, Wardlaw JM. Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol. 2023 Jul;22(7):602-618 URL: Neuroimaging standards for research into small vessel disease—advances since 2013 - The Lancet Neurology
20. Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, Dodick DW, Sunna R, Menon B, Wright C, Lynch C, Chadha AS, Ferretti MT, Dé A, Catsman-Berrevoets CE, Gichu M, Tassorelli C, Oliver D, Paulus W, Mohammed RK, Charway-Felli A, Rostasy K, Feigin V, Craven A, Cunningham E, Galvin O, Perry AH, Fink EL, Baneke P, Helme A, Laurson-Doube J, Medina MT, Roa JD, Hogl B, O'Bryan A, Trenkwalder C, Wilmshurst J, Akinyemi RO, Yaria JO, Good DC, Hoemberg V, Boon P, Wiebe S, Cross JH, Haas M, Jabalpurwala I, Mojasevic M, DiLuca M, Barbarino P, Clarke S, Zuberi SM, Olowoyo P, Owolabi A, Oyesiku N, Maly-Sundgren PC, Norrving B, Soekadar SR, van Doorn PA, Lewis R, Solomon T, Servadei F. Global synergistic actions to improve brain health for human development. Nat Rev Neurol. 2023 Jun;19(6):371-383. Global synergistic actions to improve brain health for human development - PMC (nih.gov)
CURRENT STUDENTS
Doctoral Level
1. Project Title: Genetics and epigenetic of vascular cognitive impairment in West African stroke survivors; Motunrayo Coker (July 2024)
2. Project Title: Effect of educational intervention on knowledge, perception, and behavioural intention toward brain donation among retirees in Southwest, Nigeria; Olorunyomi Olorunsogbon (December 2024)
3. Project Title: Comprehensive assessment of stroke outcomes in Abeokuta (Castro); Olaleye Adeniji (May 2024)
PREVIOUS STUDENTS (Selected)
Master’s Level
1. Project Title: The genetic association of APOL1 G1 rs73885319 variant with vascular cognitive impairment among stroke survivors in Nigeria and Ghana; Adeyemi Akinade (2021)
2. Project Title: Generalized linear models of long – term outcomes up to four years among stroke survivors in Abeokuta and Ibadan, Nigeria; Gabriel Ogunde (2021)
3. Project Title: Risk factors for hemorrhagic stroke with Apolipoprotein G1 variant among case – control pairs in Nigeria and Ghana; Ifeoluwa Olabode (2023)
Fellowship /West African College of Physicians (FWACP)/ Fellow Medical College of Physicians
Dissertations submitted to the West African Postgraduate Medical College in part fulfilment of the requirements for the award of the fellowship of the West African College of Physicians in the Faculty of Clinical Science
1. Abosede Adegbite (October 2013), The burden of caregiving of stroke survivors attending medical outpatient clinics in Abeokuta, Nigeria.
2. Funmilola Taiwo (May 2014), Frequency, associated risk factors and pattern of cognitive dysfunction in stroke survivors at three months: a case – control study.
3. Folajimi Otubogun (April 2016), Pattern and profile of adult neurological disorders in Odeda LGA, southwestern Nigeria
4. Oluyinka Kayode (October 2016), Renal function and stroke outcomes in Abeokuta, Nigeria.
5. Olaleye Adeniji (April 2017), A comparative study of the biomarker and clinical profile of Parkinson’s disease patients at Abeokuta (Nigeria) and North Tyneside (United Kingdom).
6. Oluwaseun Oluwaranti (October 2017), Validation of the Screen for Cognitive Impairment in Psychiatry (SCIP) in patients with schizophrenia in a Neuropsychiatric Hospital in Southwestern Nigeria.
7. Akintomiwa Makanjuola (April 2019), Post-stroke infections (urinary tract infection and pneumonia) and their association with short -term stroke outcomes.
8. Ayotunde Bisi (April 2020), Post-stroke pain: the frequency, profile, determinants and association with quality of life in stroke survivors seen at UCH Ibadan, Nigeria.
9. Richard Oguntoye (October 2020), Sleep disorders and their effect on the quality of life in patients with Parkinson's disease in Ibadan.
10. Akinlolu Ajani (May 2021), Left Ventricular Functions in patients with stroke: pattern, correlates and influence on short term outcomes.
|
Facebook: Profile Link
|
LinkedIn: Profile Link
|
Twitter: Profile Link
|
|
Instagram: Profile Link
|
YouTube: Profile Link
|
Pinterest: Profile Link
|
